Patent · US Active

Intracameral sustained release therapeutic agent implants

US8647659B2 · kind B2 · utility

39Cited by
16References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 21, 2011
Grant dateFeb 11, 2014
Priority date
Expiry dateJul 31, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P27/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are intracameral implants including at least one therapeutic agent for treatment of at least one ocular condition. The implants described herein are not anchored to the ocular tissue, but rather are held in place by currents and gravity present in the anterior chamber of an eye. The implants are preferably polymeric, biodegradable and provide sustained release of at least one therapeutic agent to both the trabecular meshwork and associated ocular tissue and the fluids within the anterior chamber of an eye.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.